Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), a new unit that aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients' lives.
Japan-based drugs company Takeda Pharmaceuticals could launch its early-stage development initiative as early as next month after a shake-up of its corporate venturing unit.
Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), a new unit that aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients’ lives. He reports to Tadataka Yamada, who became Takeda’s first chief medical and scientific officer after the role was created in November following…
